PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
6,710,352
Share change
-4,046,756
Total reported value
$1,380,205
Put/Call ratio
15%
Price per share
$0.20
Number of holders
26
Value change
-$1,796,168
Number of buys
6
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q3 2019

As of 30 Sep 2019, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,710,352 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, GROUP ONE TRADING, L.P., SG Americas Securities, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, WEDBUSH SECURITIES INC, J. Goldman & Co LP, UBS Group AG, MEITAV DASH INVESTMENTS LTD, and FEDERATED INVESTORS INC /PA/. This page lists 26 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.